UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: December 21, 2018
Accession Number: 0001193125-18-348308
Submission Type: POS AM
CIK: 0001114220
Company Name: KERYX BIOPHARMACEUTICALS INC
File Number: 333-190353
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Keryx Biopharmaceuticals, Inc. (delisted)
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Keryx Biopharmaceuticals, Inc. (delisted)